electroCore Inc (ECOR)
7.238
+0.22
(+3.11%)
USD |
NASDAQ |
May 08, 16:00
7.89
+0.65
(+9.01%)
After-Hours: 20:00
electroCore Enterprise Value: 33.12M for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 08, 2024 | 33.12M |
| May 07, 2024 | 31.81M |
| May 06, 2024 | 31.69M |
| May 03, 2024 | 27.64M |
| May 02, 2024 | 26.40M |
| May 01, 2024 | 25.92M |
| April 30, 2024 | 27.12M |
| April 29, 2024 | 23.88M |
| April 26, 2024 | 24.24M |
| April 25, 2024 | 23.58M |
| April 24, 2024 | 23.16M |
| April 23, 2024 | 23.64M |
| April 22, 2024 | 23.40M |
| April 19, 2024 | 23.58M |
| April 18, 2024 | 23.52M |
| April 17, 2024 | 23.19M |
| April 16, 2024 | 22.74M |
| April 15, 2024 | 23.70M |
| April 12, 2024 | 24.12M |
| April 11, 2024 | 25.62M |
| April 10, 2024 | 24.66M |
| April 09, 2024 | 25.74M |
| April 08, 2024 | 24.78M |
| April 05, 2024 | 25.80M |
| April 04, 2024 | 27.79M |
| Date | Value |
|---|---|
| April 03, 2024 | 27.85M |
| April 02, 2024 | 25.02M |
| April 01, 2024 | 26.40M |
| March 28, 2024 | 26.70M |
| March 27, 2024 | 24.90M |
| March 26, 2024 | 26.64M |
| March 25, 2024 | 26.22M |
| March 22, 2024 | 27.25M |
| March 21, 2024 | 28.09M |
| March 20, 2024 | 27.91M |
| March 19, 2024 | 31.27M |
| March 18, 2024 | 31.69M |
| March 15, 2024 | 29.53M |
| March 14, 2024 | 26.22M |
| March 13, 2024 | 28.39M |
| March 12, 2024 | 26.95M |
| March 11, 2024 | 29.35M |
| March 08, 2024 | 30.55M |
| March 07, 2024 | 30.55M |
| March 06, 2024 | 29.65M |
| March 05, 2024 | 29.47M |
| March 04, 2024 | 30.19M |
| March 01, 2024 | 30.19M |
| February 29, 2024 | 31.27M |
| February 28, 2024 | 31.19M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.47M
Minimum
Mar 18 2020
130.49M
Maximum
May 09 2019
26.30M
Average
19.50M
Median
Apr 28 2020
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 1.025B |
| Retractable Technologies Inc | -13.04M |
| Xtant Medical Holdings Inc | 122.80M |
| Asensus Surgical Inc | 47.58M |
| Catheter Precision Inc | 0.9896M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.032M |
| Revenue (Quarterly) | 5.191M |
| Total Expenses (Quarterly) | 9.149M |
| EPS Diluted (Quarterly) | -0.55 |
| Gross Profit Margin (Quarterly) | 78.81% |
| Profit Margin (Quarterly) | -77.67% |
| Earnings Yield | -48.36% |
| Normalized Earnings Yield | -48.36 |